Influence of β 2-adrenoceptor gene polymorphisms on β 2-adrenoceptor-mediated responses in human lung mast cells

British Journal of Pharmacology

Volumn 152, Issue 3, 2007, Pages 323-331

  Kay, L J ^a   Rostami Hodjegan, A ^a   Suvarna, S K ^b   Peachell, P T ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

2 adrenoceptor; ADRB2; Desensitization; Mast cells; SNP

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; HISTAMINE; IMMUNOGLOBULIN E; ISOPRENALINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DESENSITIZATION; DRUG POTENCY; FEMALE; FUNCTIONAL ASSESSMENT; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; INHIBITION KINETICS; LUNG MAST CELL; LUNG PARENCHYMA; MALE; MAST CELL; PRIORITY JOURNAL; PROMOTER REGION; CYTOLOGY; DRUG EFFECT; GENETICS; LUNG; METABOLISM; OPEN READING FRAME; TIME;

ADRENERGIC BETA-AGONISTS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; GENOTYPE; HAPLOTYPES; HISTAMINE; HUMANS; IMMUNOGLOBULIN E; ISOPROTERENOL; LUNG; MALE; MAST CELLS; OPEN READING FRAMES; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, ADRENERGIC, BETA-2; TIME FACTORS;

EID: 34848820089     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707400     Document Type: Article

References (46)

1. Ali H, Pearce FL (1985). Isolation and properties of cardiac and other mast cells from the rat and guinea-pig. Agents Actions 16: 138-140.
2. 2-adrenergic receptor among Turks. Br J Clin Pharmacol 48: 761-764.
3. 2-agonists on inflammatory cells. J Allergy Clin Immunol 104: S10-S17.
4. 2-Adrenoceptor polymorphisms. Pharmacogenetics 15: 267-275.
5. 2 Adrenoceptor gene polymorphisms in cystic fibrosis lung disease. Pharmacogenetics 12: 347-353.
6. Butchers PR, Skidmore IF, Vardey CJ, Wheeldon A (1980). Characterisation of the receptor mediating the anti-anaphylactic activities of β-adrenoceptor agonists in human lung tissue in vitro. Br J Pharmacol 71: 663-667.
7. Butchers PR, Vardey CJ, Johnson M (1991). Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br J Pharmacol 104: 672-676.
8. 2-adrenoceptor on desensitization in human lung mast cells. Pharmacogenetics 10: 153-162.
9. 2-adrenoceptor-mediated responses in human lung mast cells. Br J Pharmacol 121: 717-722.
10. 2-adrenoceptor agonists in human lung mast cells. Br J Pharmacol 138: 512-520.
11. Church MK, Hiroi J (1987). Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol 90: 421-429.
12. 2-Adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population. Clin Exp Allergy 28: 442-448.
13. Drury DEJ, Chong LK, Ghahramani P, Peachell PT (1998). Influence of receptor reserve on β-adrenoceptor-mediated responses in human lung mast cells. Br J Pharmacol 124: 711-718.
14. 2- adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 97: 10483-10488.
15. Ennis M (1991). Current techniques of histamine determination: automated fluorometric assays. Handb Exp Pharmacol 97: 31-38.
16. Gilbert HS, Ornstein L (1975). Basophil counting with a new staining method using alcian blue. Blood 46: 279-282.
17. Graham DE (1978). The isolation of high molecular weight DNA from whole organisms or large tissue masses. Anal Biochem 85: 604-613.
18. 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 268: 23116-23121.
19. s. Eur J Pharmacol 421: 141-147.
20. 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 13: 25-33.
21. 2-adrenergic receptor structure. Pulmon Pharmacol 8: 1-10.
22. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33: 9414-9419.
23. 2-Adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study. Lancet 368: 771-779.
24. Hein L (2001). Physiological significance of β-adrenergic receptor polymorphisms: in vivo or in-vitro veritas? Pharmacogenetics 11: 187-189.
25. Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ et al. (2004). Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 364: 1505-1512.
26. 2-Adrenergic receptor 50 haplotypes influence promoter activity. Br J Pharmacol 137: 1213-1216.
27. Kirstein SI, Insel PA (2004). Autonomic nervous system Pharmacogenomics: a progress report. Pharmacol Rev 56: 31-52.
28. 2-adrenoceptor agonists on mast cells of rat, guinea pig, and human. Int Arch Allergy Immunol 105: 177-180.
29. 2- adrenergic receptor and asthma exacerbations. Thorax 61: 925-927.
30. 2 Adrenoceptor polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells. Thorax 57: 61-66.
31. 2-adrenoceptor. Mol Pharmacol 48: 316-325.
32. 2-adrenergic receptor regulate receptor expression. J Clin Invest 102: 1927-1932.
33. Nials AT, Ball DI, Butchers PR, Coleman RA, Humbles AA, Johnson M et al. (1994). Formoterol on airway smooth muscle and human lung mast cells - a comparison with salbutamol and salmeterol. Eur J Pharmacol 251: 127-135.
34. Nightingale JA, Rogers DF, Barnes PJ (1999). Differential effect of formoterol on adenosine monophosphate and histamine reactivity in asthma. Am J Respir Crit Care Med 159: 1786-1790.
35. 2-agonists. Greater protection against adenosine monophosphate- than methacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 150: 381-387.
36. 2-adrenergic receptor in lymphocytes. Am J Respir Crit Care Med 172: 322-328.
37. Palmer CNA, Lipworth BJ, Lee S, Ismail T, Macgregor DF, Mukhopadhyay S (2006). Arginine-16 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol. Thorax 61: 940-944.
38. 2 adrenergic receptor mRNA inhibits receptor synthesis. J Biol Chem 269: 4497-4505.
39. 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 8: 334-339.
40. 2-adrenoceptor-mediated responses by salmeterol and formoterol. Br J Pharmacol 141: 163-171.
41. 2- adrenergic receptor gene. Br J Pharmacol 126: 841-844.
42. 2- adrenergic receptor polymorphisms in the Childhood Asthma Management Program. J Allergy Clin Immunol 112: 870-876.
43. 2-adrenoceptor polymorphism. Thorax 55: 762-767.
44. Taylor DR, Kennedy MA (2002). Beta-adrenergic receptor polymorphisms and drug responses in asthma. Pharmacogenomics 3: 173-184.
45. Waldeck B (2002). β-Adrenoceptor agonists and asthma - 100 years of development. Eur J Pharmacol 445: 1-12.
46. 2-adrenoceptor gene. Immunogenetics 56: 625-630.